Company intelligence / Profile preview

ElastiMed

Ownership: Private
Development stage: Preclinical

Overview

ElastiMed’s wearable medical device—Robotic Stocking—has demonstrated a 141% average increase in peak flow velocity after 30 minutes of use in an initial clinical study on healthy subjects. Results are comparable to standard pneumatic compression devices. The company plans additional clinical trials and an FDA submission soon.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Israeli Innovation Authority (funding)Horizon 2020 grant recipientprivate investors including The Trendlines Group Ltd.

Beyond the preview

Go deeper on ElastiMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ElastiMed.

Explore the full profile